Longleaf Primary Care, Llc - Medicare Primary Care in Anniston, AL

Longleaf Primary Care, Llc is a medicare enrolled primary clinic (Family Medicine) in Anniston, Alabama. The current practice location for Longleaf Primary Care, Llc is 171 Town Center Dr, Anniston, Alabama. For appointments, you can reach them via phone at (256) 237-1624. The mailing address for Longleaf Primary Care, Llc is Po Box 5430, Anniston, Alabama and phone number is (256) 237-1624.

Longleaf Primary Care, Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1255062832. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (256) 237-1624.

Contact Information

Longleaf Primary Care, Llc
171 Town Center Dr
Anniston
AL 36205-4102
(256) 237-1624
Not Available

Primary Care Clinic Profile

Full NameLongleaf Primary Care, Llc
SpecialityFamily Medicine
Location171 Town Center Dr, Anniston, Alabama
Authorized Official Name and PositionRenee Davis (ADMINISTRATOR)
Authorized Official Contact2562371624
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Longleaf Primary Care, Llc
Po Box 5430
Anniston
AL 36205-0430

Ph: (256) 237-1624
Longleaf Primary Care, Llc
171 Town Center Dr
Anniston
AL 36205-4102

Ph: (256) 237-1624

NPI Details:

NPI Number1255062832
Provider Enumeration Date06/23/2022
Last Update Date06/23/2022

Medicare PECOS Information:

Medicare PECOS PAC ID4587030226
Medicare Enrollment IDO20221020000781

News Archive

DFG sets up new Research Training Groups for German researchers

To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.

New book investigates what fuels the passion for science

On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.

PD-1, PD-L1 differentially expressed in NSCLC

The expression of the immune checkpoint protein programmed death-1 receptor and its ligand varies according to tumour and patient characteristics in oncogene-addicted non-small-cell lung cancer, research indicates.

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.

Read more Medical News

› Verified 5 days ago

Medical Identifiers

Medical identifiers for Longleaf Primary Care, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1255062832NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Longleaf Primary Care, Llc acts as a billing entity for following providers:
Provider NameHoward E Mcveigh
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1356404776
PECOS PAC ID: 7719907732
Enrollment ID: I20090702000572

News Archive

DFG sets up new Research Training Groups for German researchers

To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.

New book investigates what fuels the passion for science

On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.

PD-1, PD-L1 differentially expressed in NSCLC

The expression of the immune checkpoint protein programmed death-1 receptor and its ligand varies according to tumour and patient characteristics in oncogene-addicted non-small-cell lung cancer, research indicates.

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.

Read more Medical News

› Verified 5 days ago

Provider NameHala Shama Mourtada
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1417372509
PECOS PAC ID: 6608099528
Enrollment ID: I20140522000889

News Archive

DFG sets up new Research Training Groups for German researchers

To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.

New book investigates what fuels the passion for science

On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.

PD-1, PD-L1 differentially expressed in NSCLC

The expression of the immune checkpoint protein programmed death-1 receptor and its ligand varies according to tumour and patient characteristics in oncogene-addicted non-small-cell lung cancer, research indicates.

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.

Read more Medical News

› Verified 5 days ago

Provider NameBradley Elliott
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1700267507
PECOS PAC ID: 7315255072
Enrollment ID: I20150929001864

News Archive

DFG sets up new Research Training Groups for German researchers

To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.

New book investigates what fuels the passion for science

On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.

PD-1, PD-L1 differentially expressed in NSCLC

The expression of the immune checkpoint protein programmed death-1 receptor and its ligand varies according to tumour and patient characteristics in oncogene-addicted non-small-cell lung cancer, research indicates.

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.

Read more Medical News

› Verified 5 days ago

News Archive

DFG sets up new Research Training Groups for German researchers

To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.

New book investigates what fuels the passion for science

On April 8, 1982, alone in a laboratory, chemist Dan Shechtman looked through an electron microscope and saw an impossible pattern. He had discovered quasicrystals. But his groundbreaking findings were rejected, even mocked, by the scientific establishment for years.

PD-1, PD-L1 differentially expressed in NSCLC

The expression of the immune checkpoint protein programmed death-1 receptor and its ligand varies according to tumour and patient characteristics in oncogene-addicted non-small-cell lung cancer, research indicates.

Positive results from Shire's velaglucerase alfa Phase III study for Type 1 Gaucher disease

Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.

Read more News

› Verified 5 days ago


Family Medicine in Anniston, AL

Calhoun Quality Health Care
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 601 Leighton Ave, Anniston, AL 36207
Phone: 256-741-9455    
Occmed South Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 700 Quintard Ave, Suite B, Anniston, AL 36201
Phone: 256-236-9400    Fax: 256-238-1498
Carla N. Thomas, Md & Linda Dubois, Crnp
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 216 E 8th St, Anniston, AL 36207
Phone: 256-237-0215    Fax: 256-237-0295
Lhm Clinic, P.c.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1306 Leighton Ave, Anniston, AL 36207
Phone: 256-236-3031    Fax: 256-236-3202
Keith Patrick Smith Md Llc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 901 Leighton Ave, Ste 705, Anniston, AL 36207
Phone: 256-231-1322    Fax: 256-231-1324
George I Crawford Jr Md Pc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1105 Woodstock Ave, Anniston, AL 36207
Phone: 256-240-7272    Fax: 256-240-7242
Robert Cater Md Pc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1425 Greenbrier Dear Rd, Anniston, AL 36207
Phone: 256-770-4327    Fax: 256-770-4309

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.